Long-term effects of HTLV-1 on brain astrocytes: Sustained expression of Tax-1 associated with synthesis of inflammatory mediators

Journal of NeuroVirology

Volumn 6, Issue 4, 2000, Pages 350-357

  Szymocha, R ^a   Brisson, C ^a   Bernard, A ^a   Akaoka, H ^a   Belin, M F ^a   Giraudon, P ^a  

^a INSERM   (France)

Author keywords

Astrocyte activation; Cytokine; Inflammation; Metalloproteinase; Retrovirus; Zymography

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 1ALPHA; TAX PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IN VITRO STUDY; INFLAMMATION; LYMPHOID CELL LINE; MEDIATOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T LYMPHOCYTE;

ANIMALIA; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0033868529     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009030761     Document Type: Article

References (53)

1. Persistence of Viruses
2. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
3. HTLV-I-induced T-cell activation
4. Viral infections of neuroglial cells
5. Molecular profile of reactive astrocytes-implications for their role in neurologic disease
6. Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/ tropical spastic paraparesis patients
7. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
8. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis
9. Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells
10. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I)
11. Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I
12. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-I infected patients with tropical spastic paraparesis
13. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases (MMPs) and their endogenous inhibitors, TIMPs, in human astrocytes: Relevance to HTLV-I-induced neurological disease
14. Recall antigen presentation by gamma-interferon-activated microglia results in T cell activation and propagation of the immune response
15. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients
16. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: A possible pathomechanism of HAM/TSP
17. Cellular immune responses to HTLV-I: Immunopathogenic role in HTLV-I- associated neurologic disease
18. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
19. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
20. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction
21. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/ tropical spastic paraparesis: Correlation with increased HTLV-I proviral DNA load
22. Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis
23. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy
24. In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy
25. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization
26. Induction of HLA class II in HTLV-I infected neuronal cell lines
27. Discriminative presence of tissue inhibitor of metalloproteinase TIMP-3 in association with matrix metalloproteinase-9 and neopterin, in the cerebrospinal fluid of HTLV-I infected neurologic patients vs. healthy virus carriers
28. Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells
29. Mechanisms of tumor necrosis factor alpha action on neurodegeneration: Interaction with insulin-like growth factor-1
30. Interferon regulatory factor element and interferon regulatory factor 1 in the induction of major histocompatibility complex class I genes in neural cells
31. Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: Double staining of immunohistochemistry and polymerase chain reaction in situ hybridization
32. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: Induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells
33. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis
34. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes
35. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP
36. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells
37. Rous-Whipple Award Lecture. Viruses and diseases of the twenty-first century
38. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositive as well as in patients with tropical spastic paraparesis
39. Review: Neuronal injury in HIV infection
40. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
41. In vivo cellular tropism of human T-cell leukemia virus type 1
42. Differential expression of B7 costimulatory molecules by astrocytes correlates with T cell activation and cytokine production
43. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells
44. The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1
45. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes
46. Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes
47. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy
48. Human and simian glial cells infected by human T-lymphotropic virus type I in culture
49. The dynamics of HTLV-I and the CTL response
50. Increased susceptibility of human fetal astrocytes to human T- lymphotropic virus type I in culture
51. Matrix metalloproteinases and diseases of the CNS
52. Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer